Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1986-05-09
1987-10-13
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
435253, C12N 120, A61K 3902
Patent
active
046997865
ABSTRACT:
A Bordetella pertussis vaccine is prepared by deep tank cultivation using a seed grown in a biphasic culture system. An anion exchange resin in combination with .beta.-lactoglobulin and a Modified Cohen-Wheeler or Modified Stainer-Schlolte medium is used in the process resulting in enhancement of the growth, antigen production and potency of the phase I Bordetella pertussis vaccine. An acellular Bordetella pertussis vaccine derived from the culture broth and cells of Bordetella pertussis useful in preparing an acellular vaccine and which are grown in a medium containing .beta.-lactoglobulin and an anion exchange resin is also disclosed.
REFERENCES:
patent: 3577319 (1971-05-01), Nielsen et al.
patent: 4429046 (1984-01-01), Lin et al.
Kirk-Othmer, Encyclopedia of Chemical Technology, vol. 13, 1969, p. 569.
Griffith William A.
Lin Wenlii
American Cyanamid Company
Raymond R. P.
Schain Howard E.
LandOfFree
Enhanced large scale cultivation of bordetella pertussis cells f does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhanced large scale cultivation of bordetella pertussis cells f, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced large scale cultivation of bordetella pertussis cells f will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-410460